Impact of diabetes mellitus on clinical outcomes and quality of life after transcatheter aortic valve implantation for severe aortic valve stenosis
pl
dc.type
JournalArticle
pl
dc.description.physical
100-107
pl
dc.abstract.en
Background: Diabetes mellitus (DM) is considered a marker of poor prognosis after
cardiac surgery. We sought to investigate the effect of DM on clinical outcomes and quality of
life (QoL) after transcatheter aortic valve implantation (TAVI).
Methods: A total of 148 consecutive patients with symptomatic, severe aortic stenosis who underwent TAVI were included. Baseline characteristics, procedural and long-term clinical outcomes, and the results of frailty and QoL assessment with EQ-5D-3L questionnaire were
compared between patients with and without DM.
Results: DM was present in 48 of 148 (32.4%) patients. No differences in periprocedural risk
(Logistic Euroscore and Society of Thoracic Surgeons (STS) scale) between groups were
observed. There were no differences in 30-day and 12-month all-cause mortality between
groups [DM( ) vs. DM(þ): 7 (7.0%) vs. 5 (10.4%), p Z 0.53 and 12 (12.0%) vs. 10 (20.8%),
p Z 0.16, respectively]. No influence of DM presence on the risk of death was confirmed after
adjustment for age and gender (for 30-day mortality, age/gender-adjusted OR 1.55, 95%CI 0.47
e5.17; for 12-month mortality, age/gender-adjusted OR 2.05, 95%CI 0.79e5.32). Similarly, at
the longest available follow-up, mortality did not differ between groups [14 (29.2%) vs. 19
(19.0%), p Z 0.16; age/gender-adjusted OR 1.81, 95%CI 0.80e4.08]. Similar rates of other
complications after TAVI were noted. Frailty measured with the 5-meter walking test was more frequently reported in patients with DM [11 (22.9%) vs. 10 (10.0%), p Z 0.035]. No differences
in QoL parameters at baseline and 12 months were noted.
Conclusions: Patients with DM undergoing TAVI demonstrated similar mortality, complication
rates, and QoL outcomes compared to patients without DM
pl
dc.subject.en
frailty
pl
dc.subject.en
transcatheter aortic valve replacement
pl
dc.subject.en
aortic valve disease
pl
dc.subject.en
high-risk patients
pl
dc.subject.en
registry
pl
dc.description.volume
59
pl
dc.description.number
2
pl
dc.description.points
20
pl
dc.identifier.doi
10.1016/j.hjc.2017.08.002
pl
dc.identifier.eissn
2241-5955
pl
dc.title.journal
Hellenic Journal of Cardiology
pl
dc.language.container
eng
pl
dc.affiliation
Wydział Lekarski : Instytut Kardiologii
pl
dc.subtype
Article
pl
dc.rights.original
CC-BY-NC-ND; inne; ostateczna wersja wydawcy; w momencie opublikowania; 0
Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa